Market News: White House National Security Adviser jack sullivan is expected to visit Israel on Thursday to hold talks on Syrian and Gaza hostages and a ceasefire agreement.Puli Pharmaceutical Co., Ltd.: The company is under investigation by the China Securities Regulatory Commission, and there is a risk of being forced to withdraw from the market due to major violations of laws and regulations. Puli Pharmaceutical announced that the company received the Notice of Filing from the China Securities Regulatory Commission on July 7, 2024 for being suspected of violating laws and regulations in information disclosure. At present, the investigation by China Securities Regulatory Commission is still in progress, and the company has not received any conclusive opinions or decisions on the above-mentioned investigation. If the facts identified by the China Securities Regulatory Commission's administrative punishment are followed up, and the company touches the situation of forced delisting due to major violations of laws stipulated in the Listing Rules of Growth Enterprise Market of Shenzhen Stock Exchange, the company's shares are at risk of being forced to be delisted due to major violations of laws.A total of about 19,400 winning numbers of Lanyu shares were released, and Lanyu shares disclosed the online winning results of initial public offering. There are 19,400 winning numbers, and each winning number can only subscribe for 500 A shares of Zhejiang Lanyu Digital Technology Co., Ltd..
Huafa shares: it is planned to issue convertible corporate bonds of no more than 5.5 billion yuan. Huafa shares announced that the company plans to issue convertible corporate bonds of no more than 5.5 billion yuan to no more than 35 specific targets. Among them, Huafa Group, the controlling shareholder of the company, promised to subscribe for the convertible bonds in cash, and the subscription amount was not less than 29.64% of the actual issuance amount of the convertible bonds and not more than 2.75 billion yuan.Dongfang Jincheng: In 2025, the policy interest rate cut may reach 0.5 percentage points. the Political Bureau of the Communist Party of China (CPC) Central Committee held a meeting on December 9 to analyze and study the economic work in 2025. Dongfang Jincheng judges that in 2025, the central bank will continue to implement vigorous interest rate cuts and RRR cuts, among which the policy rate cuts may reach 0.5 percentage points, which is significantly higher than the rate cut of 0.3 percentage points this year, and the interest rates of various structural monetary policy instruments will also be lowered in a timely manner, thus guiding the financing costs of enterprises and residents to go down. It is not ruled out that in 2025, it is possible to continue to implement a large-scale targeted interest rate cut on residential mortgages by greatly guiding the downward trend of LPR quotations for more than five years. (The Paper)Dongfang Jincheng: In 2025, the policy interest rate cut may reach 0.5 percentage points. the Political Bureau of the Communist Party of China (CPC) Central Committee held a meeting on December 9 to analyze and study the economic work in 2025. Dongfang Jincheng judges that in 2025, the central bank will continue to implement vigorous interest rate cuts and RRR cuts, among which the policy rate cuts may reach 0.5 percentage points, which is significantly higher than the rate cut of 0.3 percentage points this year, and the interest rates of various structural monetary policy instruments will also be lowered in a timely manner, thus guiding the financing costs of enterprises and residents to go down. It is not ruled out that in 2025, it is possible to continue to implement a large-scale targeted interest rate cut on residential mortgages by greatly guiding the downward trend of LPR quotations for more than five years. (The Paper)
MicroStrategy, a big bitcoin holder, bought 21,550 bitcoins on December 2-8.Cube Pharmaceutical's mid-term profit distribution plan for 2024: It is planned to send 10 parties to 2 yuan. Cube Pharmaceutical disclosed its mid-term profit distribution plan for 2024 on the evening of December 9, and plans to distribute a cash dividend of 2 yuan (including tax) to all shareholders for every 10 shares. Based on this preliminary calculation, the company plans to distribute a total cash dividend of 38,252,100 yuan (including tax).Jingxing Paper: The second phase of Malay project is expected to start in the first quarter of 2025. Jingxing Paper said in an institutional survey on December 9 that the capacity utilization rate of the company's packaging paper is relatively high, except for necessary maintenance and downtime, it is basically in the state of full-load operation, and the annual output this year is about 1.5 million tons. On the issue of the company's capital expenditure plan in the later period, Jingxing Paper said that the company's largest capital expenditure plan at present is the Malay Phase II project, which is expected to be officially launched in the first quarter of next year, with an estimated construction period of two years.